title: Receptor status (ER, PgR and HER2) discordance between primary tumor and locoregional recurrence in breast cancer.
authors.forename: S
authors.initials: S
authors.lastname: Zurrida
authors.forename: E
authors.initials: E
authors.lastname: Montagna
authors.forename: P
authors.initials: P
authors.lastname: Naninato
authors.forename: M
authors.initials: M
authors.lastname: Colleoni
authors.forename: A
authors.initials: A
authors.lastname: Goldhirsch
mesh_terms: D001943:Breast Neoplasms / Q000378:metabolism* / Q000473:pathology / Q000628:therapy; D003131:Combined Modality Therapy; D005260:Female; D006801:Humans; D007150:Immunohistochemistry; D008875:Middle Aged; D009364:Neoplasm Recurrence, Local; D018719:Erb-b2 Receptor Tyrosine Kinases / Q000378:metabolism*; D011960:Receptors, Estrogen / Q000378:metabolism*; D011980:Receptors, Progesterone / Q000378:metabolism*
chemical_list: D018719:Erb-b2 Receptor Tyrosine Kinases; D011960:Receptors, Estrogen; D011980:Receptors, Progesterone; C508053:ERBB2 protein, human